Cetera Advisors’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,417
Closed -$27K 1464
2022
Q1
$27K Sell
1,417
-100
-7% -$1.91K ﹤0.01% 1380
2021
Q4
$27K Sell
1,517
-809
-35% -$14.4K ﹤0.01% 1412
2021
Q3
$86K Buy
2,326
+769
+49% +$28.4K ﹤0.01% 1358
2021
Q2
$93K Sell
1,557
-32
-2% -$1.91K ﹤0.01% 1291
2021
Q1
$106K Buy
1,589
+79
+5% +$5.27K ﹤0.01% 1184
2020
Q4
$91K Buy
1,510
+32
+2% +$1.93K ﹤0.01% 1015
2020
Q3
$117K Sell
1,478
-380
-20% -$30.1K ﹤0.01% 916
2020
Q2
$116K Buy
1,858
+65
+4% +$4.06K ﹤0.01% 873
2020
Q1
$95K Sell
1,793
-319
-15% -$16.9K 0.01% 762
2019
Q4
$250K Buy
2,112
+12
+0.6% +$1.42K 0.01% 785
2019
Q3
$384K Buy
2,100
+209
+11% +$38.2K 0.02% 622
2019
Q2
$251K Buy
1,891
+336
+22% +$44.6K 0.01% 771
2019
Q1
$380K Buy
1,555
+189
+14% +$46.2K 0.02% 575
2018
Q4
$265K Sell
1,366
-110
-7% -$21.3K 0.02% 671
2018
Q3
$488K Buy
1,476
+432
+41% +$143K 0.02% 576
2018
Q2
$322K Sell
1,044
-105
-9% -$32.4K 0.02% 642
2018
Q1
$281K Buy
1,149
+176
+18% +$43K 0.02% 632
2017
Q4
$294K Buy
973
+119
+14% +$36K 0.02% 584
2017
Q3
$225K Buy
854
+38
+5% +$10K 0.01% 713
2017
Q2
$214K Buy
816
+60
+8% +$15.7K 0.01% 711
2017
Q1
$272K Buy
756
+61
+9% +$21.9K 0.02% 608
2016
Q4
$202K Hold
695
0.02% 643
2016
Q3
$237K Sell
695
-240
-26% -$81.8K 0.02% 618
2016
Q2
$400K Sell
935
-211
-18% -$90.3K 0.03% 485
2016
Q1
$367K Buy
1,146
+40
+4% +$12.8K 0.03% 476
2015
Q4
$573K Buy
1,106
+25
+2% +$13K 0.05% 371
2015
Q3
$316K Buy
1,081
+40
+4% +$11.7K 0.03% 477
2015
Q2
$409K Buy
1,041
+25
+2% +$9.82K 0.03% 429
2015
Q1
$308K Hold
1,016
0.03% 494
2014
Q4
$225K Buy
1,016
+20
+2% +$4.43K 0.02% 567
2014
Q3
$232K Buy
996
+40
+4% +$9.32K 0.02% 505
2014
Q2
$211K Buy
956
+230
+32% +$50.8K 0.02% 532
2014
Q1
$228K Hold
726
0.03% 452
2013
Q4
$189K Buy
726
+246
+51% +$64K 0.03% 467
2013
Q3
$70K Sell
480
-70
-13% -$10.2K 0.01% 437
2013
Q2
$83K Buy
+550
New +$83K 0.02% 377